Previously, CRISPR-Cas9 screens in two chordoma cell lines had identified the developmental transcription factor T (brachyury), renamed TBXT, to be the top selectively essential gene in chordoma, relative to 125 non-chordoma cancer cell lines17. This evidence concerns the gene TBXT and cancer.